PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote ()	3/3/1998 11:17:00 PM
From: Miljenko Zuanic	Read Replies (1) of 626

Hi TD: Nice initial TTNP cover-up. I guess you by purpose missed anticancer drug(s) acquired from Ansan collaboration. This compounds should also be kept in mind. >>ILOPEODONE treats both positive and negative schizophrenic symptoms, and has less side effects as indicate in Phase II trials.<< Any more details on PII data? Effectiveness on positive and negative symptoms and lower side effects are to general description and does not show much. As you know, Iloperidone will be tested against Risperidone (J&J), but LLY's Olanzapine is today lead drug on market. mz

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next